search
Back to results

Effectiveness and Safety of Rhubarb for the Treatment of Patients Who Have Suffered From Cerebral Hemorrhage

Primary Purpose

Lung Infection, Cerebral Hemorrhage, Pneumonia

Status
Unknown status
Phase
Phase 2
Locations
China
Study Type
Interventional
Intervention
rhubarb
Placebo
Sponsored by
Fudan University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Lung Infection focused on measuring Lung Infection After Cerebral Hemorrhage, Prevention of Pneumonia, Rhubarb

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Occurrence of an acute cerebral hemorrhage (between 9 and 72 h after onset) with a score of at least 6 on the National Institute of Health Stroke Scale (NIHSS), and patient age of at least 18 years.
  • Have no pneumonia according to modified criteria of the U.S. Centers for Disease Control and Prevention (CDC)
  • Consistent with the Constipation of Phlegm-Heat Accumulation type by Traditional Chinese Medicine (TCM) standard
  • Patients or their representatives voluntarily take part in this study and signed the informed consent

Exclusion Criteria:

  • Cerebral infarction, transient ischemic attack(TIA)
  • Subarachnoid hemorrhage
  • Proven cerebral embolism caused by tumor, Brain Trauma, cerebral parasitic disease, dysbolismus, fibrillation atrial resulted from rheumatic heart disease, coronary heart disease, and other heart diseases
  • Clinical signs of infection on admission
  • Pregnant or breast-feeding
  • Allergic to rhubarb
  • Preceding or ongoing antibiotic therapy within the last 24 h
  • Participation in another interventional trial
  • Immunosuppressant treatment within the last 30 days
  • Combining severe clinical conditions such as liver, kidney, Hematopoietic System, endocrine system or psychological diseases

Sites / Locations

  • Zhongshan hospital of Fudan University

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Placebo Comparator

Arm Label

A

B

Arm Description

Outcomes

Primary Outcome Measures

The lung infection rate within 14 days after stroke onset

Secondary Outcome Measures

Global disability on modified Rankin scale at 90 days
NIH stroke scale
Barthel Index
Death rate
Syndrome score by Traditional Chinese Medicine (TCM) standard
Changes in laboratory indexes as safety assessment, including red blood cell(RBC), white blood cell(WBC), platelet(PLT), alanine transaminase (ALT), aspartate transaminase(AST), blood urea nitrogen (BUN), creatinine(Cr) in blood samples; protein,

Full Information

First Posted
December 29, 2008
Last Updated
May 26, 2010
Sponsor
Fudan University
search

1. Study Identification

Unique Protocol Identification Number
NCT00815737
Brief Title
Effectiveness and Safety of Rhubarb for the Treatment of Patients Who Have Suffered From Cerebral Hemorrhage
Study Type
Interventional

2. Study Status

Record Verification Date
September 2009
Overall Recruitment Status
Unknown status
Study Start Date
January 2009 (undefined)
Primary Completion Date
undefined (undefined)
Study Completion Date
undefined (undefined)

3. Sponsor/Collaborators

Name of the Sponsor
Fudan University

4. Oversight

5. Study Description

Brief Summary
This study will determine if rhubarb will reduced the incidence of pneumonia and improved recovery from an acute cerebral hemorrhage. The study is designed to look at both infection rate and overall recovery and recovery of motor function, for example muscle strength and coordination.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Lung Infection, Cerebral Hemorrhage, Pneumonia
Keywords
Lung Infection After Cerebral Hemorrhage, Prevention of Pneumonia, Rhubarb

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 2, Phase 3
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
100 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
A
Arm Type
Experimental
Arm Title
B
Arm Type
Placebo Comparator
Intervention Type
Drug
Intervention Name(s)
rhubarb
Intervention Description
14 days of rhubarb
Intervention Type
Drug
Intervention Name(s)
Placebo
Intervention Description
14 days of Placebo
Primary Outcome Measure Information:
Title
The lung infection rate within 14 days after stroke onset
Time Frame
14 days
Secondary Outcome Measure Information:
Title
Global disability on modified Rankin scale at 90 days
Time Frame
90 days
Title
NIH stroke scale
Time Frame
90 days
Title
Barthel Index
Time Frame
90 days
Title
Death rate
Time Frame
90 days
Title
Syndrome score by Traditional Chinese Medicine (TCM) standard
Time Frame
90 days
Title
Changes in laboratory indexes as safety assessment, including red blood cell(RBC), white blood cell(WBC), platelet(PLT), alanine transaminase (ALT), aspartate transaminase(AST), blood urea nitrogen (BUN), creatinine(Cr) in blood samples; protein,
Time Frame
90 days

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Occurrence of an acute cerebral hemorrhage (between 9 and 72 h after onset) with a score of at least 6 on the National Institute of Health Stroke Scale (NIHSS), and patient age of at least 18 years. Have no pneumonia according to modified criteria of the U.S. Centers for Disease Control and Prevention (CDC) Consistent with the Constipation of Phlegm-Heat Accumulation type by Traditional Chinese Medicine (TCM) standard Patients or their representatives voluntarily take part in this study and signed the informed consent Exclusion Criteria: Cerebral infarction, transient ischemic attack(TIA) Subarachnoid hemorrhage Proven cerebral embolism caused by tumor, Brain Trauma, cerebral parasitic disease, dysbolismus, fibrillation atrial resulted from rheumatic heart disease, coronary heart disease, and other heart diseases Clinical signs of infection on admission Pregnant or breast-feeding Allergic to rhubarb Preceding or ongoing antibiotic therapy within the last 24 h Participation in another interventional trial Immunosuppressant treatment within the last 30 days Combining severe clinical conditions such as liver, kidney, Hematopoietic System, endocrine system or psychological diseases
Facility Information:
Facility Name
Zhongshan hospital of Fudan University
City
Shanghai
State/Province
Shanghai
ZIP/Postal Code
200032
Country
China

12. IPD Sharing Statement

Citations:
PubMed Identifier
15719749
Citation
Cai DF, Dai W, Chen YP, Wen M, Dai HL. [Effect and mechanism of rhubarb on fibrinolysis in secondary damaged central nerve system of rats with acute hemorrhagic stroke]. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2005 Jan;25(1):38-41. Chinese.
Results Reference
background

Learn more about this trial

Effectiveness and Safety of Rhubarb for the Treatment of Patients Who Have Suffered From Cerebral Hemorrhage

We'll reach out to this number within 24 hrs